The Ceo Of Opioid Drug Maker Amerisourcebergen Got A $14M Payday Thanks To A Controversial Accounting Method - The Washington Post

by washingtonpost.com posted 4months ago 20 views
The substantial payout was only possible because the Pennsylvania-based drug distributor relied on a controversial accounting method: excluding legal settlement costs from its year-end CEO evaluation.

In this article